bf/NASDAQ:VRTX_icon.jpeg

NASDAQ:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

USD

Last Close

471.38

21/06 20:00

Market Cap

110.85B

Beta: 0.49

Volume Today

2.75M

Avg: 1.12M

PE Ratio

31.95

PFCF: 26.33

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients ...Show More

Earnings

Earnings per Share (Estimate*)

12342015-10-282017-10-252019-10-302021-11-022023-11-06

Revenue (Estimate*)

1B2B3B4B2015-10-282017-10-252019-10-302021-11-022023-11-06

*Estimate based on analyst consensus